4.09 USD
+0.08 (+2.01%)
4.23 USD
+0.14 (+3.42%)
MOLN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. MOLN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MOLN is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- MOLN had negative earnings in the past year.
- MOLN had a negative operating cash flow in the past year.
- In the past 5 years MOLN reported 4 times negative net income.
- In the past 5 years MOLN reported 4 times negative operating cash flow.
1.2 Ratios
- MOLN has a Return On Assets (-48.19%) which is comparable to the rest of the industry.
- MOLN's Return On Equity of -56.57% is fine compared to the rest of the industry. MOLN outperforms 64.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.19% | ||
| ROE | -56.57% | ||
| ROIC | N/A |
ROA(3y)-6.8%
ROA(5y)-18.16%
ROE(3y)-7.72%
ROE(5y)-28.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of MOLN (99.80%) is better than 99.05% of its industry peers.
- MOLN's Gross Margin has been stable in the last couple of years.
- MOLN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 99.8% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5Y0.01%
2. Health
2.1 Basic Checks
- MOLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- MOLN has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, MOLN has more shares outstanding
- Compared to 1 year ago, MOLN has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -0.11, we must say that MOLN is in the distress zone and has some risk of bankruptcy.
- MOLN has a Altman-Z score (-0.11) which is in line with its industry peers.
- MOLN has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of MOLN (0.00) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.11 |
ROIC/WACCN/A
WACC4.88%
2.3 Liquidity
- MOLN has a Current Ratio of 9.28. This indicates that MOLN is financially healthy and has no problem in meeting its short term obligations.
- MOLN's Current ratio of 9.28 is fine compared to the rest of the industry. MOLN outperforms 79.43% of its industry peers.
- A Quick Ratio of 9.28 indicates that MOLN has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 9.28, MOLN is in the better half of the industry, outperforming 79.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.28 | ||
| Quick Ratio | 9.28 |
3. Growth
3.1 Past
- MOLN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.05%, which is quite good.
- MOLN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.38%.
- Measured over the past years, MOLN shows a very negative growth in Revenue. The Revenue has been decreasing by -24.59% on average per year.
EPS 1Y (TTM)16.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.65%
Revenue 1Y (TTM)-29.38%
Revenue growth 3Y-20.13%
Revenue growth 5Y-24.59%
Sales Q2Q%-100%
3.2 Future
- MOLN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.81% yearly.
- MOLN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 96.98% yearly.
EPS Next Y6.91%
EPS Next 2Y4.57%
EPS Next 3Y19.94%
EPS Next 5Y-3.81%
Revenue Next Year-83.33%
Revenue Next 2Y35.4%
Revenue Next 3Y108.01%
Revenue Next 5Y96.98%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- MOLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MOLN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as MOLN's earnings are expected to grow with 19.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.57%
EPS Next 3Y19.94%
5. Dividend
5.1 Amount
- MOLN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MOLECULAR PARTNERS AG -ADR / MOLN FAQ
What is the ChartMill fundamental rating of MOLECULAR PARTNERS AG -ADR (MOLN) stock?
ChartMill assigns a fundamental rating of 2 / 10 to MOLN.
What is the valuation status for MOLN stock?
ChartMill assigns a valuation rating of 0 / 10 to MOLECULAR PARTNERS AG -ADR (MOLN). This can be considered as Overvalued.
Can you provide the profitability details for MOLECULAR PARTNERS AG -ADR?
MOLECULAR PARTNERS AG -ADR (MOLN) has a profitability rating of 2 / 10.
What is the financial health of MOLECULAR PARTNERS AG -ADR (MOLN) stock?
The financial health rating of MOLECULAR PARTNERS AG -ADR (MOLN) is 4 / 10.
Can you provide the expected EPS growth for MOLN stock?
The Earnings per Share (EPS) of MOLECULAR PARTNERS AG -ADR (MOLN) is expected to grow by 6.91% in the next year.